Back
Opus Genetics, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
43
IRD
Opus Genetics, Inc.
Last Price:
$2.24
Seasonality Move:
-17.2%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiOpus Genetics, Inc. Stock Forecast
-
Is Opus Genetics, Inc. Stock Undervalued?The current Opus Genetics, Inc. [IRD] share price is $2.23. The Score for IRD is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
IRD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Opus Genetics, Inc. Stock Go Up Next Year?
Data Unavailable
Opus Genetics, Inc. Stock Rating
Data Unavailable
Opus Genetics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
opusgtx.com
52-Week Data
52-Week High:
2.37
52-Week Low:
0.65
Prediction Charts
Market Cap:
153.8M
Price in USD:
2.23
Volume:
382.9K
Beta:
2.81
Technical Analysis
SMA50:
1.97
SMA100:
1.60
SMA200:
1.29
52-Wk Change:
85.83%
Stock Predictions
-
Is Opus Genetics, Inc. stock public?Yes, Opus Genetics, Inc. is a publicly traded company.
-
What is the Opus Genetics, Inc. stock quote today?The Opus Genetics, Inc. stock price is 2.23 USD today.
-
How to buy Opus Genetics, Inc. stock online?You can buy Opus Genetics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.83 | 1.88 | 1.93 | 1.80 |
| Nov-17 | 1.85 | 1.74 | 1.91 | 1.74 |
| Nov-18 | 1.72 | 1.88 | 1.89 | 1.70 |
| Nov-19 | 1.88 | 1.86 | 1.91 | 1.80 |
| Nov-20 | 1.88 | 1.93 | 2.05 | 1.87 |
| Nov-21 | 1.93 | 1.91 | 1.95 | 1.86 |
| Nov-24 | 1.94 | 2.00 | 2.01 | 1.94 |
| Nov-25 | 2.03 | 1.98 | 2.03 | 1.92 |
| Nov-26 | 2.01 | 2.02 | 2.05 | 1.98 |
| Nov-28 | 2.04 | 2.13 | 2.15 | 2.03 |
| Dec-1 | 2.11 | 2.00 | 2.11 | 1.97 |
| Dec-2 | 2.00 | 1.99 | 2.06 | 1.97 |
| Dec-3 | 2.03 | 2.09 | 2.12 | 1.99 |
| Dec-4 | 2.09 | 2.23 | 2.29 | 2.06 |
Opus Genetics, Inc. Earnings
Data Unavailable
Opus Genetics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.19 per share.
* Opus Genetics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.